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The CNS is prone to heterogeneous insults of diverse etiologies that elicit multifaceted responses. Acute and
focal injuries trigger wound repair with tissue replacement. Diffuse and chronic diseases provoke gradually
escalating tissue changes. The responses to CNS insults involve complex interactions among cells of
numerous lineages and functions, including CNS intrinsic neural cells, CNS intrinsic nonneural cells, and
CNS extrinsic cells that enter from the circulation. The contributions of diverse nonneuronal cell types to
outcome after acute injury, or to the progression of chronic disease, are of increasing interest as the push
toward understanding and ameliorating CNS afflictions accelerates. In some cases, considerable information
is available, in others, comparatively little, as examined and reviewed here.Introduction
Amajor goal of contemporary neuroscience is to understand and
ameliorate a wide range of CNS disorders. Toward this end,
there is increasing interest in cellular and molecular mechanisms
of CNS responses to damage, disease, and repair. Neurons are
the principal cells executing neural functions and have long
dominated investigations into mechanisms underlying CNS dis-
orders. Nevertheless, mounting evidence indicates that treating
all types of CNS disorders will require a deeper understanding of
how multicellular responses to injury and disease are triggered,
evolve, resolve (or not), and impact on neuronal function.
The ability to repair tissue damaged by injury is fundamental to
vertebrate biology and central to survival. Evolutionary pressure
is likely to have forged certain fundamental cellular and molecu-
lar responses to damage that are common across different tis-
sues. The wound or injury response in skin has long served as
a model system for dissecting mechanisms of tissue repair after
acute focal tissue damage and has provided insight into core
cellular and molecular interactions (Greaves et al., 2013; Gurtner
et al., 2008; Singer and Clark, 1999). In addition, organ-specific
features exist. Organ-intrinsic cells that are specialized in inflam-
matory regulation and tissue repair are emerging as critical
elements in organ-specific responses to insults. Organ-specific
features apply particularly in the CNS, where glial cells, which
maintain the cytoarchitecture and homeostatic regulation
without which neurons could not function normally in healthy tis-
sue, are also principal responders to CNS insults. Changes in
glial cell function during responses to insults have the potential
to impact markedly on neuronal interactions and CNS functions.
CNS insults are caused by diverse etiologies that can elicit a
wide range of responses. For example, acute and focal injuries
trigger wound repair with tissue replacement, whereas diffuse
and chronic diseases can trigger gradually escalating tissue
changes. Analysis of similarities and differences in such re-
sponses can provide valuable insights. Cellular responses to
CNS insults involve complex interactions among cells of
numerous lineages and functions, including CNS intrinsic neural
cells, CNS intrinsic nonneural cells, and CNS extrinsic cells thatenter from the circulation. The biology of cell types that partici-
pate in CNS responses to injury and disease models has gener-
ally been studied in isolation. There is increasing need to study
interplay of different cells to understand mechanisms. This Re-
view examines and reviews the multiple cell types involved in,
and contributing to, different types of CNS insults. In some
cases, extensive information is available, in others, compara-
tively little.
Terminology
Various terms used in discussions of CNS injury and disease
can be subject to different interpretations. In this Review, we
will define and use certain specific terms as follows. ‘‘Reactive
gliosis’’ will refer not only to microglia and astroglia, but also to
glial cells that have come to be known as NG2-positive oligoden-
drocyte progenitor cells (NG2-OPCs). Glial cells in healthy CNS
tissue will not be referred to as ‘‘resting’’ or ‘‘quiescent.’’ This
is an antiquated concept. Glia are highly active in healthy CNS
and dynamically exert complex functions that play critical roles
in normal CNS functions (Barres, 2008; Sofroniew and Vinters,
2010). For example, astrocytes exhibit physiological activation
in the form of transient, ligand-evoked elevations in intracellular
calcium ([Ca2+]i) that represent a type of astrocyte excitability,
which is under intense investigation as a potential means of
mediating dynamic astrocyte functions, including interactions
with synapses and regulation of blood flow (Attwell et al., 2010;
Halassa and Haydon, 2010; Tong et al., 2013; Verkhratsky
et al., 1998). Microglia perform essential roles in synapse devel-
opment and turnover (Stephan et al., 2012; Stevens et al., 2007).
The term ‘‘activated’’ is often used in a binary all-or-none fashion
to define glial cells that have responded to insults. We feel that
use of the term in this manner is inaccurate in two ways. First,
it does not recognize that glia are continually being ‘‘activated’’
in physiological contexts. Second, as discussed throughout
this Review, glial cell responses to CNS insults are not binary
and are highly diverse and specifically regulated. To differentiate
physiological activation of glial cells in healthy contexts from re-
sponses associated with injury or disease, we will use the term
‘‘reactive,’’ which is also meant denote a broad spectrum ofNeuron 81, January 22, 2014 ª2014 Elsevier Inc. 229
Table 1. Diverse Cell Types in CNS Responses to Damage and
Disease
CNS Intrinsic Cells Blood-Borne Nonneural Cells
CNS Intrinsic Neural Cells Leukocytes
Neurons Monocyte/macrophage
Oligodendrocytes Neutrophils
Astrocytes Eosinophils
NG2-OPC NK cells
Neural stem/progenitor cells T cells
Ependyma B cells
CNS Intrinsic Nonneural Cells Other Bone Marrow-Derived Cells
Microglia Platelets (thrombocytes)
Perivascular fibroblasts Fibrocytes
Pericytes Mesenchymal (bone marrow
stromal) stem cells
Endothelia and progenitors
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avoid use of the term ‘‘scar’’ on its own and will instead distin-
guish between ‘‘astrocyte scars’’ that form compact borders
around tissue lesions and ‘‘fibrotic scars’’ that are formed by
multiple nonneural cell types and extracellular matrix within
lesion cores (as discussed in detail below). We will equate ‘‘glial
scar’’ with ‘‘astrocyte scar.’’
Multicellular Response to CNS Insults
Before discussing the different types of responses to CNS dam-
age and disease, it is useful briefly to introduce different cell
types involved in these responses. For ease of consideration,
we have grouped cells according to lineages as (1) neural and
nonneural cells intrinsic to CNS and (2) blood-borne nonneural
cells that derive primarily from bone marrow (Table 1). Some of
these cell types have been studied extensively in CNS disorders,
others comparatively little. Most often they have been studied in
isolation. In subsequent sections, we will endeavor to examine
their interactions.
CNS Intrinsic Neural Cells
The principal neural-lineage cells in the CNS, neurons, oligoden-
drocytes and astrocytes, have been studied and reviewed exten-
sively as regards their individual responses to CNS injury and
disease (Barres, 2008; Franklin and Ffrench-Constant, 2008;
Mattson, 2000; Sofroniew and Vinters, 2010). Less well studied
are glial cells that have come to be known as NG2-positive oligo-
dendrocyte progenitor cells (NG2-OPCs). Like other glia, NG2-
OPC tile the CNS and respond to CNS insults (Nishiyama
et al., 2009). Features of the NG2-OPC response include migra-
tion toward injury and cell proliferation (Franklin and Ffrench-
Constant, 2008; Hughes et al., 2013). Besides replacing lost
oligodendrocytes (Sun et al., 2010), other roles of NG2-OPC in
CNS injury and disease await future study and elucidation. In
addition, the adult CNS harbors neural stem cells (NSCs) of
different potencies that reside in the periependymal regions
along the ventricles and central canal in adult brain and spinal
cord (Garcia et al., 2004; Kriegstein and Alvarez-Buylla, 2009).
These adult NSCs can also respond to CNS injury and generate230 Neuron 81, January 22, 2014 ª2014 Elsevier Inc.progenitors and cells of different types that migrate to sites of
injury (Benner et al., 2013; Lagace, 2012; Meletis et al., 2008;
Ohab and Carmichael, 2008).
CNS Intrinsic Nonneural Cells
Various nonneural-lineage cells intrinsic to CNS play critical roles
in CNS damage and disease (Table 1). Microglia are well docu-
mented as highly sensitive early responders that stimulate and
recruit other cells, as well phagocytose debris (Hanisch and
Kettenmann, 2007; Kreutzberg, 1996; Nimmerjahn et al., 2005;
Ransohoff and Perry, 2009). Fibroblast-related cells, including
perivascular fibroblasts, meningeal fibroblasts, and pericytes,
contribute to tissue replacement by forming fibrotic scar tissue
after severe damage (Go¨ritz et al., 2011; Klapka and Mu¨ller,
2006; Logan and Berry, 2002; Soderblom et al., 2013; Winkler
et al., 2011). Endothelia and endothelial progenitors are promi-
nent during tissue replacement after CNS injury (Loy et al.,
2002; Oudega, 2012) and are of increasing interest in CNS repair
in light of their emerging roles as trophic support cells in CNS
development (Dugas et al., 2008) and their ability to produce
and present laminin (Davis and Senger, 2005), a preferred growth
substrate for many migrating cells and axons.
Blood-Borne Nonneural Cells
Blood-borne immune and inflammatory cells of different kinds
(Table 1) play prominent roles in CNS responses to damage
and disease and have been studied and reviewed (Perry, 2010;
Popovich and Longbrake, 2008). In addition to well-known roles
in phagocytosis and removal of debris, there is also now
increasing evidence that subtypes of leukocytes play active roles
in tissue repair (Derecki et al., 2012; London et al., 2013; Popo-
vich and Longbrake, 2008). Platelets aggregate rapidly after
damage for clot formation and haemostasis. Other blood-borne,
bone marrow-derived cell types that home in to tissue injury,
including in CNS, include fibrocytes (Aldrich and Kielian, 2011;
Reilkoff et al., 2011) and bone marrow-derived mesenchymal
stem cells (Askari et al., 2003; Bianco et al., 2001; Jaerve et al.,
2012), but their functions are not well understood.
Extracellular Matrix
Extracellular matrix (ECM) generated by different cells plays crit-
ical roles in tissue repair and replacement after acute insults, as
well as in chronic tissue remodeling during chronic disease (Mid-
wood et al., 2004). Molecules that modify ECM matrix, such as
metaloproteases (MMPs), are also important in this regard (Mid-
wood et al., 2004). In the CNS, ECM generated by different cell
types responding to damage or disease can include a wide vari-
ety of molecules such as laminin, collagens, and glycoproteins
such as chondroitin or heparan sulfate proteoglycans (CSPGs
or HSPGs) that are implicated both in supporting tissue repair
as well as in contributing to the failure of axonal regeneration
(Davis and Senger, 2005; Klapka and Mu¨ller, 2006; Logan and
Berry, 2002; Silver and Miller, 2004).
Response to Focal Insults
Two principal types of acute focal insults in the CNS are focal
traumatic injury and ischemic stroke. In addition to being major
clinical problems, they have for decades served as prototypical
experimental models with which to study CNS mechanisms of
response to damage and repair. In this section, we will examine
basic features of CNS multicellular responses to acute focal
Figure 1. Phases and Time Course of Multicellular Responses to Acute Focal CNS Damage
During periods of cell death (A), cell replacement (B), and tissue remodeling (C), numerous overlapping events occur (D) that involve interactions among CNS
intrinsic neural cells, CNS intrinsic nonneural cells, and cells infiltrating from the circulation.
Neuron
Reviewinjuries and how these change over time, using information from
response to trauma or stroke as models. In this regard, it is note-
worthy that acute focal trauma caused by contusion or crush re-
sults in severe vascular damage and therefore exhibits many
sequelae similar to stroke. We will make comparisons with the
acute wound response in skin as a model system for cellular
and molecular mechanisms of wound repair (Greaves et al.,
2013; Gurtner et al., 2008; Shechter and Schwartz, 2013; Singer
and Clark, 1999). As in skin repair, CNS responses to acute focal
damage can also be divided broadly into three overlapping but
distinct phases: (1) cell death and inflammation, (2) cell prolifer-
ation for tissue replacement, and (3) tissue remodeling (Figure 1).We will first examine CNS responses in a context in which the
acute insults remain uninfected and resolve. Below, we will
also briefly consider more chronic focal CNS insults, including
focal infections with abscess formation, primary and secondary
tumors, and chronic focal autoimmune lesions, such as multiple
sclerosis plaques, which exhibit various features and cellular re-
sponses similar to traumatic and ischemic injury. In order to pre-
sent succinct summaries of cellular responses and interactions,
discussion of information about underling molecular signals is
deferred to a later section below. It deserves mention that the
time courses given for response phases and events are general-
ized approximations (Figure 1), and there is much potential forNeuron 81, January 22, 2014 ª2014 Elsevier Inc. 231
Figure 2. Lesions Exhibit Tissue
Compartments and Signaling Gradients
(A and B) Focal damage gives rise to lesions
with distinct tissue compartments in the form of
nonneural lesion cores (LC), newly proliferated
compact astrocyte scars (AS), and perilesion pe-
rimeters (PLP) that exhibit diminishing gradients of
reactive gliosis that transition gradually to healthy
tissue (HT). AS abruptly demarcate the transition
between nonneural LC and PLP with viable neural
cells. Size of the lesion core and the location of
AS, and this transition, are regulated by opposing
molecular signals. Gradients of molecular signals
emanating from LC impact on cells in PLP.
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specific situations.
Phase I: Cell Death and Inflammation
After focal CNS tissue damage from insults such as trauma or
ischemia that cause acute local cell death, the first phase of
response in the injury center or core includes both very rapid
events that occur over timescales of seconds to hours and
more gradually progressing events that develop over days (Fig-
ures 1A and 1D). Very rapid events include haemostasis with
coagulation cascade, platelet aggregation, and clot formation.
These rapid events are followed by overlapping sequences of re-
sponses of tissue intrinsic cells, recruitment of inflammatory and
immune cells, subacute death of parenchymal cells, and initiation
of debris removal (Figures1Aand1D). In healthyCNS tissue, large
and polarmolecules in the circulation are excluded fromdiffusion
into CNS parenchyma by the blood-brain barrier (BBB) (Abbott
et al., 2006; Zlokovic, 2008). After focal insults with BBB damage,
blood-borne molecules normally excluded from the CNS influx
and signal to local cells, as discussed in more detail below in
the section on molecular signaling. Platelets influx and rapidly
form aggregates for haemostasis and also signal to local cells.
Fibrin and collagen matrices begin to form over a period from
hours to days, which serve as a scaffold for neutrophil and then
macrophage and other leukocyte infiltration. Leukocytes then
infiltrate heavily to monitor for pathogens, remove debris, and
providemolecular signals involved inwound repair over a variable
number of days or longer depending on severity of tissue damage
or presence of exacerbating factors (Figures 1A and 1D) (Perry,
2010; Popovich and Longbrake, 2008). Endogenous mesen-
chymal stem cells may also enter the lesion core, but their roles
are not well understood (Askari et al., 2003; Bianco et al., 2001;
Jaerve et al., 2012). These basic cellular events reflect classic
wound responses as found in other tissues (Greaves et al.,
2013; Gurtner et al., 2008; Singer and Clark, 1999).
Certain CNS intrinsic cells also respond rapidly to CNS tissue
damage or BBB leak. Live imaging studies in CNS in vivo show
that microglia and NG2-OPC immediately migrate to sites of tis-
sue damage and BBB leak (Hughes et al., 2013; Nimmerjahn232 Neuron 81, January 22, 2014 ª2014 Elsevier Inc.et al., 2005). Astrocytes, in contrast,
remain in situ and do not migrate either
to or away from injury sites but can
swell osmotically and, depending on the
severity of injury or ischemia, can die
in the center of severe lesions or canbecome reactive and hypertrophy and in some cases proliferate
(Bardehle et al., 2013; Zheng et al., 2010). Different aspects of
this first phase of response occur in overlapping sequences dur-
ing the first few days and then begin gradually diminishing
(Figure 1D), provided that the insult is a single acute event not
complicated by bony compression, infection, or other exacerba-
tions thatmight prolong the damaging insult. As acute responses
diminish, there is overlap with the onset of different types of cell
proliferation associated with the next phase of responses (Fig-
ures 1B and 1D).
Phase II: Cell Proliferation and Tissue Replacement
The second phase of response to acute CNS tissue damage oc-
curs from about 2 to 10 days after the insult and is characterized
by the proliferation and local migration of cells that implement tis-
sue repair and replacement. These cells include endothelial pro-
genitors, fibroblast-lineage cells, different types of inflammatory
cells, andvarious typesof glia andneural-lineageprogenitor cells,
including scar-forming astrocytes and their progenitors (Figures
1B and 1D). Some of these cellular proliferative phenomena,
such as proliferation of endothelia for neovascularization (Casella
et al., 2002) or proliferation of certain fibroblast-lineage cells or in-
flammatory cells, reflect classic wound responses (Gurtner et al.,
2008; Singer and Clark, 1999), while others, such as proliferation
of scar-forming astrocytes, are specific and unique to CNS. This
phase is also characterized throughout its duration by the
absence of a BBB in the lesion core during the period in which
damaged blood vessels are replaced by new ones (Figure 1D).
As a consequence, endogenous (as well as exogenous) proteins
and other chargedmolecules can freely diffuse into the surround-
ing neural parenchyma (Bush et al., 1999). These molecules can
include serum proteins (e.g., thrombin, albumin) that signal to
local cells, immunoglobulins, or pathogen-associatedmolecules,
as discussed below. This leaky BBB creates the potential for the
lesion core to serve as source of circulating molecules that
generate gradients of molecular signaling that can extend for
considerable distances into neural tissue around the lesion until
the BBB is repaired (Figures 1B, 1D, 2A, and 2B). This signaling
may contribute to the perimeter of tapering gradient of reactive
Neuron
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lesions as discussed below.
During the proliferative phase, cellular elements are generated
that will in mature lesions form two of the threemajor tissue com-
partments of the mature lesion, (1) the central lesion core of non-
neural tissue and (2) the compact astrocyte scar that surrounds
the lesion core (Figures 1B and 1D). Major cellular components
of the nonneural lesion core derive from expansion of CNS
intrinsic perivascular fibroblasts and pericytes (Go¨ritz et al.,
2011; Soderblom et al., 2013) and from proliferating endothelial
progenitors. The compact astrocyte scar is formed primarily
from newly proliferated elongated astrocytes generated by local
astroglial progenitors that gather around the edges of severely
damaged tissue containing inflammatory and fibroblast-lineage
cells (Figures 1B and 1D) (Faulkner et al., 2004; Sofroniew and
Vinters, 2010; Wanner et al., 2013). It is noteworthy that during
this proliferative period, the location of compact astrocyte scar
borders is being determined. In mature lesions, these astrocyte
scar borders will precisely demarcate and separate persisting
areas of nonfunctional, nonneural lesion core tissue from imme-
diately surrounding and potentially functional neural tissue (Fig-
ures 1B, 2A, and 2B). Cellular and molecular mechanisms that
underlie the determination of precisely where such astrocyte
scar borders are formed are incompletely understood but are
likely to involve a complex interplay and balance of molecular
signals that on the one hand foster phagocytosis and debris
clearance and signals that on the other hand foster protection
and preservation of healthy self (Figure 2B), as discussed in
more detail below in the section on molecular signals of cell
damage and death. Several decades of experimental studies
on ischemic infarcts show that final lesion size can be influenced
by subacute metabolic events that continue for hours to days
within penumbral zones around the lesions (Astrup et al., 1981;
Dirnagl et al., 1999; Lo, 2008). In addition, astrocyte intrinsic
signaling cascades have been identified that play critical roles
(Herrmann et al., 2008; Okada et al., 2006; Wanner et al.,
2013). A better understanding of the multicellular and molecular
interactions that determine the location of astrocyte scar borders
around areas of compromised tissue may lead to novel thera-
peutic strategies for reducing lesion size (Figure 2B). These
events occur over a time frame of days after the insult
(Figure 1D), during which intervention is a realistic possibility.
Recent findings also indicate that during the proliferative
phase after acute CNS damage in the forebrain, neural stem cells
in periventricular germinal zones give rise to considerable
numbers of neural progenitors that migrate to the injury sites
in cortex or striatum (Carmichael, 2006; Kokaia et al., 2012;
Lagace, 2012; Lindvall and Kokaia, 2006). These cells form
part of the mix of cells in perilesion perimeters (Figures 1B and
1C). There are various lines of evidence suggesting that these
cells may contribute beneficially to tissue remodeling in perile-
sion tissue, but the nature of the contributions made by these
cells remains nebulous. Under normal, unmanipulated circum-
stances, very few newly generated neurons mature and survive,
and other potential contributions by these intriguing, migrating
progenitor cells, such as contributions to immune regulation,
are still in the process of being defined (Kokaia et al., 2012;
Lagace, 2012).Phase III: Tissue Remodeling
The third phase of response to acute tissue damage generally
begins toward the end of the first week after the insult and is
distinguished by tissue remodeling that includes events that
are completed within weeks, such as BBB repair and scar orga-
nization, as well as chronic events that can continue over many
months (Figures 1C and 1D). BBB repair or restoration along
newly formed blood vessels in the lesion vicinity is generally
completed within several weeks after acute uncomplicated in-
sults and requires the presence of functional astrocytes (Bush
et al., 1999) and pericytes (Daneman et al., 2010; Winkler et al.,
2011). The lesion core of nonneural tissue becomes surrounded
by a well-organized, interdigitating compact astrocyte scar by 2–
3 weeks after acute insults not exacerbated by ongoing tissue
damage (Figures 1C and 1D) (Wanner et al., 2013). These scar-
forming astrocytes appear actively to corral and surround inflam-
matory and fibroblast-lineage cells during tissue remodeling and
scar formation (Wanner et al., 2013). This compact astrocyte
scar forms a structural and functional border between nonneural
tissue in the central lesion core and the immediately adjacent
and surrounding neural tissue that contains viable cells of all
three neural-lineage cell types, astrocytes, oligodendrocytes,
and neurons (Figures 1C and 2) (Wanner et al., 2013). This astro-
cyte scar border serves as a protective barrier that restricts the
migration of inflammatory cells from the nonneural lesion core
into surrounding viable neural tissue. Disruption of astrocyte
scar formation in different kinds of transgenic loss-of-function
models leads to increased lesion size, increased death of local
neurons, increased demyelination, and decreased recovery of
function after traumatic or ischemic focal insults (Bush et al.,
1999; Faulkner et al., 2004; Herrmann et al., 2008; Li et al.,
2008; Wanner et al., 2013). After compact astrocyte scar forma-
tion, the second period of tissue remodeling is long lasting, with
gradual remodeling of lesion core, astrocyte scar border, and
surrounding perimeter regions (Figures 1D and 2). For example,
with time there is gradual contraction of lesion cores and astro-
cyte scars. As transected axons continue to die back away from
lesions, oligodendrocyte death can continue, leading to local tis-
sue responses and remodeling. There is long-term remodeling of
ECM in the lesion core, with modulation of collagen and glyco-
protein components (Klapka and Mu¨ller, 2006; Logan and Berry,
2002; Silver and Miller, 2004). In addition, there is gradual and
chronically ongoing tissue remodeling in reactive perimeter
regions that surround mature lesions, as discussed next.
Mature Lesions Exhibit Three Tissue Compartments
Astrocyte scar formation around central lesion cores is essen-
tially complete by 2–4 weeks after acute insults that are not
complicated by prolonged tissue damage, and the lesion can
at this time be considered mature and entering its chronic stage
(Figures 1 and 2). In mature lesions, it is useful to recognize three
very distinct lesion compartments: (1) the central lesion core of
nonneural tissue comprised of locally derived fibroblast-lineage
cells, blood vessels, infiltrating fibrocytes and inflammatory
cells, and extracellular matrix; (2) the compact astrocyte scar
that immediately surrounds the lesion core and consists of
densely packed astrocytes with few if any neurons or oligoden-
drocytes; and (3) the perilesion perimeter of viable neural tissue
that is adjacent to the compact astrocyte scar and contains allNeuron 81, January 22, 2014 ª2014 Elsevier Inc. 233
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and astrocytes) and exhibits a tapering reactive gliosis that grad-
ually transitions to healthy tissue (Figure 2). All of these compart-
ments will exhibit further tissue remodeling for weeks to months.
Some of this remodeling has the potential to impact on functional
outcome and may provide targets for therapeutic interventions,
particularly in the perimeter of neural tissue that exhibits diffuse
reactive gliosis (Figures 1D and 2). It is useful to consider
separately these compartments and their impact on functional
outcome.
Lesion Core. Tissue in the mature lesion core contains few
or no neural-lineage cells and is nonfunctional in neurological
terms. Initially, the main cell types in mature lesion cores include
fibroblast-lineage cells, endothelia, fibrocytes, and inflammatory
cells (Figure 2A). With time and remodeling, and in the absence
of exacerbating damage or infection, inflammatory elements
will gradually withdraw, although some may persist for long
times. Elements of lesion core will persist permanently as fibrotic
scar containing various nonneural cells and ECM. In some areas
of lesion core, cells and ECMwill recede to leave fluid-filled cysts
of quite variable size (Figure 2A) (Tuszynski and Steward, 2012).
Functionally, cells and ECM of lesion core serve as substrates
for rapid wound repair and tissue replacement. The rapidity of
wound closure allowed by fibrotic replacement as compared
with parenchymal renewal has been suggested to afford advan-
tages in other tissues (Greaves et al., 2013; Gurtner et al., 2008;
Singer and Clark, 1999). Nevertheless, this mechanism can
come with the cost of lost tissue functions. In CNS, lesion core
tissue has since the 19th century been thought to have a negative
long-term functional impact as an impediment to axon regener-
ation, confirmed by recent studies as well (Zukor et al., 2013).
Molecular evaluations show that lesion core ECM contains colla-
gens and proteoglycans that poorly support or overtly inhibit
regrowth of damaged axons (Hermanns et al., 2006; Kimura-Kur-
oda et al., 2010; Klapka and Mu¨ller, 2006; Yoshioka et al., 2010).
Compact Astrocyte Scars (Glial Scars).Mature astrocyte scars
consist of relatively narrow zones of newly generated astrocytes
with elongated processes that intermingle and intertwine exten-
sively and that immediately abut and surround on all sides re-
gions of lesion core tissue (Figure 2A) (Sofroniew and Vinters,
2010; Wanner et al., 2013). These narrow zones of densely inter-
twined elongated scar-forming astrocytes are generally notmore
than amillimeter across and are generally devoid of other neural-
lineage cells (neurons or oligodendrocytes) (Wanner et al.,
2013). These scar-forming astrocytes are newly proliferated in
response to the insult and the packing density of astrocyte cell
bodies in astrocyte scars is up to double that in healthy tissue
(Wanner et al., 2013). The densely packed elongated scar-form-
ing astrocytes transition seamlessly and rapidly to less densely
packed and less densely intertwined hypertrophic reactive as-
trocytes that are intermingled with viable neurons and other
elements of neural tissue in the surrounding perimeter of reactive
neural tissue discussed below (Figure 2A) (Wanner et al., 2013).
Transgenic loss-of-function studies show that newly proliferated
compact astrocyte scars exert essential neuroprotective func-
tions by restricting the spread of inflammatory cells away from
tissue lesions caused by trauma, stroke, and autoimmune
inflammation. When astrocyte scar formation is experimentally234 Neuron 81, January 22, 2014 ª2014 Elsevier Inc.prevented or attenuated in vivo, inflammation spreads, lesion
size increases, neuronal loss and demyelination are exacer-
bated, and functional recovery is diminished (Bush et al., 1999;
Dro¨gemu¨ller et al., 2008; Faulkner et al., 2004; Wanner et al.,
2013). Scar-forming astrocytes are also widely regarded as a,
if not the, major impediment to axon regeneration after CNS
injury, based in part on in vitro studies showing astrocyte pro-
duction of certain proteoglycans that can inhibit elongation
(Silver et al., 1993). Nevertheless, other studies show that axon
regeneration in vivo occurs along astrocyte bridges and that, in
the absence of such bridges, axon regeneration does not occur
and seems more to be impeded by confrontation with nonneural
lesion core tissue (Kawaja and Gage, 1991; Williams et al., 2013;
Zukor et al., 2013). Transgenic loss-of-function studies conduct-
ed in vivo may help to clarify the precise nature and scale of
effects exerted by scar-forming astrocytes on axon regrowth
after injury.
Perilesion Perimeters. All mature lesion cores and astrocyte
scars are surrounded by perimeters of viable neural tissue that
exhibits a gradient of tapering reactive gliosis that gradually tran-
sitions to healthy tissue (Figure 2A) (Wanner et al., 2013). The
tissue in these perimeter zones contains all neural-lineage cell
types including neurons and oligodendrocytes, and these cells
are intermingled with reactive gliosis that can extend for consid-
erable distances (Figure 2A). Reactive perimeter tissue begins
immediately adjacent to compact astrocyte scars, where the
elongated cell processes of scar-forming astrocytes overlap
with hypertrophic reactive astrocytes and reactive microglia
that are intermingled with surviving viable neurons and other
elements of neural tissue (Figure 2A). It is somewhat remarkable
that viable neurons can be present within a few hundred micro-
meters of compact astrocyte scars and the lesion core tissue
filled with potentially cytotoxic inflammatory elements just
beyond (Bush et al., 1999;Wanner et al., 2013). The reactive glio-
sis in perimeters includes hypertrophic reactive astrocytes and
microglia (Figure 2A). Both the cause and functions of perimeters
of tapering reactive gliosis are not clear. Regarding cause, it
is possible that gradients of signaling molecules diffusing out
from the lesion core, either entering during the period of BBB
leak or produced there by infiltrating and proliferating cells,
may trigger such a gradient of gradually tapering responses
among local glia (Figures 2A and 2B). From a functional perspec-
tive, the degree to which specific aspects of this reactive gliosis
are beneficial or harmful (or some mixture of both) remains to be
determined.
Reactive perimeter areas around lesion cores in brain and spi-
nal cord are likely to exhibit long-term, and potentially intense,
tissue remodeling, with new synapse formation and the potential
for formation of new relay circuits (Bareyre et al., 2004; Carmi-
chael, 2006; Clarkson et al., 2010; Courtine et al., 2008; Li
et al., 2010; Overman et al., 2012). Numerous factors have the
potential to impact on this synapse and circuit remodeling,
including extracellular matrix molecules such as proteoglycans
in the perineuronal (Garcı´a-Alı´as et al., 2009). Reactive glia may
play important roles in this remodeling, but this topic is under-
studied. In the healthy CNS, astrocytes interact with neurons
on multiple spatial and temporal scales that can influence or
modulate neural function in various ways (Halassa and Haydon,
Neuron
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fundamental roles in the synapse remodeling in the perilesion
perimeter (Stephan et al., 2012; Stevens et al., 2007) and the
impact of reactive gliosis on such remodeling is not yet under-
stood. Such perilesion perimeter areas are likely to provide fertile
ground for investing new strategies for interventions that may
influence neural plasticity and relay circuit formation, which in
combination with appropriate rehabilitative training (van den
Brand et al., 2012) have the potential to beneficially influence
functional outcome.
Chronic Focal Insults
In addition to acute focal trauma and stroke, which often serve as
models to study mechanisms of CNS damage as just discussed,
other more chronic forms of damage warrant consideration.
Important chronic insults include focal infections with abscess
formation, tumors, and autoimmune lesions. All of these condi-
tions invoke reactive gliosis and multicellular responses that
have strong similarities with those that occur after acute focal
damage. This multicellular response plays critical roles in pro-
gression, severity, and resolution (or not) of the insults.
Infection. Focal infections or abscesses can form when
traumatic wounds become infected or can be seeded spontane-
ously, particularly in immune-compromised individuals. Such
infections elicit reactive gliosis with astrocyte scar formation
similar to that after acute focal trauma (Sofroniew and Vinters,
2010). The time course of lesion persistence and tissue remodel-
ing is protracted and dependent on resolution of the infection.
Transgenic loss-of-function studies show that astrocyte scar
formation is critical to focal containment of the infection. When
astrocyte scars are disrupted, infection and inflammation spread
rapidly through adjacent neural tissue with devastating effects
(Dro¨gemu¨ller et al., 2008).
Cancer. Both primary and metastatic tumors elicit reactive
gliosis and multicellular responses that have similarities to other
forms of focal tissue damage. Interactions of tumor cells with
CNS glia and infiltrating inflammatory cells are complex and
heavily dependent on tumor cell type. Noninvasive tumors are
surrounded by reactive gliosis and encapsulating scar similar
to that seen around traumatic tissue damage. Aggressively inva-
sive tumors are not encapsulated or surrounded by well-defined
astrocyte scars but evoke other forms of reactive gliosis and
multicellular responses. Successful infiltration and spread of
certain tumor cell types is thought to be associated with their
ability to create an environment for growth, vascularization,
and spread, which may include successfully neutralizing bar-
rier-forming functions of local CNS cells and co-opting programs
for creating proliferative niches (Louis, 2006; Silver et al., 2013;
Watkins and Sontheimer, 2012).
Autoimmune Disease. Focal autoimmune lesions are inter-
esting to consider from the perspective of being a response
to CNS damage. Although CNS autoimmune disease is often
viewed as diffuse, chronic, and caused primarily by dysfunctions
of the peripheral immune system, individual autoimmune lesions
bear many similarities to acute focal traumatic wounds. For
example, active multiple sclerosis plaques are filled with inflam-
matory cells and chronic plaques exhibit central lesion cores that
are devoid of all neural-lineage cell types (no neurons, oligoden-
drocytes, or astrocytes) surrounded by astrocyte scars thatseparate nonneural tissue from perimeters of reactive gliosis in
tissue with all three neural cell types (Frohman et al., 2006; Luc-
chinetti et al., 1996) in manners similar to tissue damage caused
by trauma or ischemia (Figures 1 and 2). Neuromyelitis optic
(NMO) is an autoimmune inflammatory disease in which causal
autoantibodies are directed against aquaporin-4 on the astro-
cyte cell membrane, and NMO lesions are associated with com-
plement-mediated, lytic destruction of astrocytes (Lennon et al.,
2005; Popescu and Lucchinetti, 2012). There is remarkable
congruence between clinical evidence from NMO and experi-
mental loss-of-function studies demonstrating that transgeni-
cally mediated ablation or attenuation of scar-forming astrocytes
results in severe exacerbation of autoimmune CNS inflammation
(Haroon et al., 2011; Voskuhl et al., 2009). Thus, both clinical and
experimental evidence implicate critical roles for scar-forming
astrocytes in limiting the spread of autoimmune CNS inflamma-
tion. These observations strongly suggest that dysfunction of
CNS intrinsic cells such as astrocytes may contribute causally
to the onset or progression of CNS autoimmune conditions in
ways not generally considered by research focused only on
trying to identify causal mechanisms of the peripheral immune
system. This notion may be further supported by suggestions
that a subgroup of patients with multiple sclerosis have dis-
ease-related autoantibodies against the potassium channel
Kir4.1, which in the CNS is located on astrocyte membranes (Sri-
vastava et al., 2012). It will be interesting to determine the extent
to which gain or loss of astrocyte functions contributes to the
pathophysiology of CNS autoimmune conditions.
Response to Diffuse Insults
Diffuse insults to CNS tissue can be associated with neurode-
generative diseases, certain seizure disorders, or mild traumatic
brain injury. Diffuse insults tend initially to be less intense than
acute focal damage caused by trauma or stroke and may not
initially cause overt tissue damage but instead accumulate grad-
ually over chronic periods of time. As the tissue damage be-
comes more severe, small individual lesions form, each of which
invokes reactive gliosis and multicellular responses similar to
those caused by acute tissue damage with breakdown of the
BBB, inflammation, and recruitment of leukocytes (Figures 1
and 2) but on a smaller scale. Over time, the diffuse damage
comes to resemble a diffuse collection of many small focal
lesions that are intermingled and can be dispersed over large
areas (Figure 3A). Each of these small lesions gives rise to its
own perilesion perimeter zones of tapering reactive gliosis,
with the consequence that overlapping zones of severe hyper-
trophic reactive gliosis and multicellular responses can be
distributed over large areas of tissue (Figure 3A). It is important
to realize that these many small lesions are interspersed among
viable neurons and neural circuitry, which become enveloped by
these overlapping perilesion perimeters of reactive gliosis (Fig-
ures 3A and 3B). As discussed above, there is now substantive
evidence for the participation of astrocytes and microglia in
normal neural circuit function, but the impact of reactive gliosis
on such functions is not known. In the context of diffuse CNS
insults, large areas of functioning neural tissue may be exposed
to intense reactive gliosis that is likely to impact on synaptic in-
teractions and neural circuit functions (Figure 3B). A betterNeuron 81, January 22, 2014 ª2014 Elsevier Inc. 235
Figure 3. Diffuse Tissue Damage Leads to Extended Regions of Reactive Gliosis
(A) Small chronic insults can lead to diffuse tissue damage with formation of dispersed small lesion cores (LC), astrocyte scars (AS), and perilesion perimeters
(PLP) that can overlap and coalesce into regions of contiguous reactive gliosis that can extend over large areas.
(B) Reactive astrocytes and reactive microglia in PLP can impact on synapses and neuronal functions in various ways.
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peutic strategies.
Neurodegenerative Disease
Reactive gliosis and multicellular responses are triggered in
different and selective ways in different neurodegenerative dis-
eases. In some cases, the trigger can be accumulation of extra-
cellular toxins, such as b-amyloid in Alzheimer’s disease (AD)
(Prokop et al., 2013; Zlokovic, 2011), which can accumulate
and cause many small areas of focal tissue damage that trigger
gliosis with many similarities to other forms of diffuse insults
(Figure 3A). In other cases, the trigger can be neuronal or synap-
tic damage or death secondary to neuronal intrinsic changes.
Some conditions, such as amyotrophic lateral sclerosis (ALS)
or Huntington’s disease, cause intrinsic cellular changes in
both neurons and glia that can perturb cellular functions and in-
teractions, which can serve as triggers (Boille´e et al., 2006; Mar-
agakis and Rothstein, 2006). Neurodegenerative insults can also
lead to disturbance of the neurovascular unit, resulting in BBB
leak, which can serve as a further trigger for reactive gliosis
and also signal to recruit blood-borne inflammatory cells (Zlo-
kovic, 2008, 2011). In many cases, reactive gliosis and multicel-
lular responsesmay not be apparent at onset or in early stages of
the neurodegenerative conditions but appear later and may then
become involved in disease progression. Reactive gliosis trig-
gered in various ways, by accumulation of abnormal proteins,
ischemic or traumatic cellular damage, or microbes, can also
lead to BBB leak via specific molecular signaling cascades as
discussed below, with resultant inflammation that may con-
tribute to disease progression.
The contributions of glial cells and reactive gliosis to neurode-
generative conditions are complex and only beginning to be
understood. Glia not only become reactive in response to degen-
erative cues as just mentioned, but can also participate in trying
to combat them. For example, both microglia and astrocytes are236 Neuron 81, January 22, 2014 ª2014 Elsevier Inc.thought to contribute to clearing b-amyloid (Prokop et al., 2013;
Wyss-Coray et al., 2003), and attenuation of reactive astrogliosis
can increase b-amyloid load in a transgenic mouse model of AD
(Kraft et al., 2013). In addition, glia may be affected by the dis-
ease-causing molecular defects and become dysfunctional,
further complicating efforts to understand the roles of reactive
gliosis in the disease process. For example, in ALS, glial cell
dysfunction is causally implicated in mediating neuronal degen-
eration (Yamanaka et al., 2008), and ongoing reactive gliosis and
inflammation are also thought to contribute to disease progres-
sion (Maragakis and Rothstein, 2006). Distinctions between
disease-induced dysfunctions of glial cells and the reactive re-
sponses that are triggered in glial cells by cell and tissue damage
are sometimes blurred or equated but should not be. Under-
standing these different phenomena and the ways in which
they interact is likely to have important consequences for under-
standing the mechanisms that underlie cellular pathophysiology
and drive disease progression. It is important to remember that
although some aspects of glial reactivity may contribute to dis-
ease progression, others are likely to be protective. Defining
themolecular basis of such differencesmay help to identify novel
therapeutic strategies.
In the context of neurodegenerative disease, it is also inter-
esting briefly to consider the potential for non-cell-autonomous
neuronal degeneration precipitated by dysfunction of glia or
other nonneural cells. Loss- or gain-of-function genetic muta-
tions in microglia (Derecki et al., 2012) or astrocytes (Brenner
et al., 2001; Rothstein, 2009; Tao et al., 2011) have the potential
to cause non-cell-autonomous degeneration of different types of
neurons in different human diseases and animal experimental
models. Such observations indicate that glial cell dysfunction
may be the primary causal event in certain neurological condi-
tions. Such observations also raise the possibility that dysfunc-
tion of specific aspects of reactive gliosis during responses to
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repair and worse outcome. The potential for genetic polymor-
phisms to impact on glial cell functions and responses to CNS
injury is an as yet untapped area that may reveal causal factors
underlying differences in the responses of different individuals
to seemingly similar types and severities of CNS insults.
Epilepsy
Astrocytes and microglia can be involved in epilepsy in multiple
ways. Astrocytes playmultiple critical roles in regulating synapse
activity and neuronal excitability and astrocytes may play critical
roles in the generation of seizure activity (Devinsky et al., 2013;
Jabs et al., 2008; Wetherington et al., 2008). In addition, reactive
gliosis of both microglia and astrocytes is a prominent feature
of chronically epileptic neural tissue, which can also exhibit
BBB breakdown and multicellular inflammation (Devinsky
et al., 2013; Jabs et al., 2008; Wetherington et al., 2008). With
increasing loss of neurons, tissue sclerosis sets in, which has
similarities with severe diffuse astrogliosis due to other causes
as discussed above, with many smaller tissue lesions sur-
rounded by a continuum of perilesion tissue with a mix of surviv-
ing neurons and increasingly severe hypertrophic gliosis
(Figure 3A). The impact of reactive gliosis and the multicellular
response to tissue damage on the surviving neurons in the peril-
esion perimeter regions is not well understood (Figure 3B) but
may contribute to reduced seizure thresholds. Selective experi-
mental induction of astrocyte reactivity is associated with a
reduction of inhibition in local hippocampal neurons (Ortinski
et al., 2010). More work in this area is warranted.
Diffuse Traumatic Brain Injury
Large focal lesions caused by severe focal traumatic brain injury
(TBI) (contusion or crush) have been discussed above. Neverthe-
less, clinically relevant TBI is often diffuse and widely distributed.
The cellular and molecular mechanisms of diffuse TBI that cause
functional disturbances without large focal lesions are incom-
pletely understood. Diffuse TBI is generally characterized by
small foci of vascular breakdown and tissue damage that can
be diffusely distributed over large areas of CNS (DeKosky
et al., 2013; McIntosh et al., 1989). It is interesting to consider
that each of these small areas of tissue or cellular damage may
represent a small focal injury with compartments equivalent to
core, astrocyte scar, and perimeter, which may be spread over
large areas without an obvious single large focal region
(Figure 3A). As discussed above, the interspersed viable neural
tissue in the many overlapping perilesion perimeter regions will
be exposed to intense hypertrophic reactive gliosis and inflam-
mation, which can impact on neural functions (Figure 3B). Spe-
cific cellular and molecular mechanisms of reactive gliosis and
multicellular responses triggered by mild or moderate diffuse
TBI are only beginning to be characterized. Newly proliferated
reactive astrocytes exert protective functions essential for
neuronal survival (Myer et al., 2006). Microglia can exert a broad
range of effects depending on specific molecular stimuli, which
either protect or exacerbate tissue loss (Hanisch and Ketten-
mann, 2007). Understanding and manipulating the reactive glio-
sis and multicellular sequelae triggered by mild to moderate TBI
has enormous potential to identify new therapeutic targets in a
field of high incidence and importance. Emerging molecular
mechanisms are discussed in the next section.Molecular Signaling and Multicellular Interactions
Molecular signaling among the different cell types that respond
to CNS insults is complex, combinatorial, and densely inter-
woven. Different cells have the capacity to produce and respond
to similar sets of molecules, and there are hints that some mole-
cules may coordinate multicellular responses. Many intercellular
signaling molecules have been identified, but we are in the early
stages of determining how these multiple signals regulate
multicellular interactions and the temporal progression from
one phase to another during responses to specific CNS insults.
Here we provide a general overview of molecular functional
classes (Figure 4A) and a few representative examples of the
many specific molecules that regulate or influence CNS cellular
responses to insults (Table 2).
Cell Damage and Death
Cells that are dead, dying, or temporarily damaged but recover-
able release or express molecules that signal damage. These
molecules fall into many categories including neurotransmitters,
cytokines, chemokines, neuroimmune-regulators (NI-Regs), and
danger-associated molecular patterns (DAMPs) that stimulate
reactive gliosis and other cellular responses including debris
clearance by immune cells (Figures 4B and 4C) (Table 2). Insults
of different types and severities release different combinations
of these molecules, which in turn trigger different responses.
For example, mild cellular insults can subtly elevate extracellular
concentrations of glutamate or ATP that attract microglial cell
processes without initially unleashing full-blown inflammation
(Figure 4B) (Davalos et al., 2005; Liu et al., 2009). ATP can
also elicit calcium responses in astrocytes and cause con-
nexin-dependent ATP release that increases extracellular ATP
levels and amplify this ‘‘danger’’ signal (Figure 4B). More severe
cell damage or death will release additional DAMPs and
alarmins in the form of cytosolic and nuclear contents such as
K+, heat shock proteins such as ab-crystallin, S100 family cal-
cium-binding proteins, DNA-binding high mobility group box 1
(HMGB1), as well of DNA and RNA. All of these molecules can
serve as ‘‘danger’’ signals to alert innate immune cells to tissue
injury and promote clearance of ‘‘altered self’’ cellular debris via
activation of pattern recognition receptors (PRRs) on phagocytic
innate immune cells (Figure 4C) (Chan et al., 2012; Griffiths et al.,
2010; Kono and Rock, 2008). Molecules such as beta-amyloid
(Ab) produced during neurodegenerative disorders can also
act as alarmins (Figure 4C). A single type of alarmin may
bind multiple classes of PPRs. For example, HMBG1 elicits
proinflammatory signaling through activation of multiple TLRs,
receptor for advanced glycation end products (RAGE), and
macrophage antigen complex-1 (MAC1) (Chan et al., 2012;
Gao et al., 2011), and S100 activates multiple TLRs and RAGE
(Chan et al., 2012).
Healthy neurons and glia near CNS insults express neuroim-
mune regulatory molecules (NI-Regs) and self-defense proteins
that signal ‘‘healthy self’’ and serve to confine potentially noxious
proinflammatory signaling and prevent phagocytosis of viable
cells (Figure 4C) (Table 2) (Griffiths et al., 2010). These ‘‘healthy
self’’ molecular signals include both membrane-bound and
soluble NI-Reg molecules. For example, sialic acids (SAs) in
membranes of healthy cells interact with SA receptors (SARs),
including Siglecs, on innate immune cells and serve as ‘‘don’tNeuron 81, January 22, 2014 ª2014 Elsevier Inc. 237
Figure 4. Multimolecular Regulation and Graded Responses to Damage
(A) Responses toCNSdamageare regulatedand influencedbydiverse categoriesofmolecular signals derived frommany typesofCNS intrinsic andextrinsic cells.
(B) Low levels of ATP released by cells during mild CNS insults can act through (1) P2X receptors to induce rapid chemotaxis of microglial processes and (2) P2Y
receptors on local astrocytes to evoke calcium signaling and connexin-dependent ATP release, which can increase extracellular ATP levels and thereby amplify
this ‘‘danger’’ signal.
(C) After severe injury, signaling molecules from ‘‘altered self’’ and ‘‘healthy self’’ vie to balance debris clearance and preservation of viable tissue. Severely
damaged or dead cells release a number of hydrophobic intracellular molecules (left), or ‘‘alarmins,’’ which express damage-associated molecular patterns
(DAMPs). These ‘‘danger’’ signals alert CNS innate immune cells to tissue injury and promote clearance of debris via activation of pattern recognition receptors on
phagocytic immune cells (center). Viable CNS intrinsic cells at lesion borders (right) expressmembrane-bound and soluble neuroimmune regulatory molecules to
prevent attack and phagocytosis by immune cells.
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and CD47 similarly act through receptors CD200R and SIRP-a
on inflammatory cells to prevent phagocytic attack (Figure 4C)238 Neuron 81, January 22, 2014 ª2014 Elsevier Inc.(Griffiths et al., 2010). Complement regulatory proteins (CRPs)
can reduce complement activation (Figure 4C) (Griffiths
et al., 2010). Thrombomodulin (CD141) binds and sequesters
Table 2. Major Classes and a Few Specific Examples of Intercellular Signaling Molecules that Regulate Cellular Responses to CNS
Damage
Molecule Source Lesion Compartment Phase Targets and Effects
Class: Protease and Related
Thrombin S LC, AS I Clot formation; astrocyte proliferation
MMP-9 M, O, S LC, AS, PLP I-III OPC proliferation, remyelination; BBB leak; neovascular remodeling
Kallikreins A, M, N, S LC, AS, PLP I-III Proinflammatory; demyelination
Serpins A, M, O LC, PLP I-III Inhibit deleterious protease
Class: NTs
ATP, Glutamate N, O, A LC, AS, PLP I Microglia chemotaxis; reactive astrogliosis
Class: DAMPs
Alarmins: HMGB1,
S100s, DNA
Damaged Cells LC, PLP I.II ‘‘Altered self’’ signals; proinflammatory; increase phagocytosis
PAMPs: LPS Microbes LC, PLP I.II ‘‘Nonself invader’’ signals; proinflammatory; increase phagocytosis
Class: Growth Factors, Morphogens
FGF A, N, E, LC, AS, PLP I-III Fibrotic scar; ECM; neovascular remodeling; reactive astrogliosis
VEGF E, P, F, A LC, AS I-III BBB permeability; neovascular remodeling
PDGF-B
PDGF-A
E, A LS, PLP I-III Neovascular remodeling
Remyelination; OPC Proliferation
Endothelin,
EGF, BMP
N, A, O LC, AS II, III Astrocyte proliferation, glial scar formation
Class: Cytokines, Chemokines
TGFb A, M, L AS, PLP I-III Fibrotic scar formation; ECM production; astrocyte proliferation
IL-1b, TNFa, INFg A, M, L LC, AS, I, II Proinflammatory regulation
IL-6, CCL2 A, M, L LC, AS I, II Leukocyte instruction, astrocyte scar formation
Class: NIRegs
CD141 A, O, E LC, AS I-III Protection of healthy self; resolution of inflammation
CD200, CD47 N LC, AS, PLP I, II Protection of healthy self
Class: Neural Remodeling
Neurotrophins,
BDNF, etc.
N, A PLP III Synapse remodeling
Perineuronal net A, OPC PLP III Restrict terminal sprouting
Thmbs, C1q A, M PLP III Synapse formation and pruning
A, astrocyte; E, endothelia; F, fibroblast; L, leukocyte; M, microglia; N, neuron; NTs, neurotransmitters; O, oligodendrocyte; OPC, O progenitor cell; S,
serum; Thmbs, thrombospondin.
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(Abeyama et al., 2005).
Thus, specific receptor-mediated signals that indicate
‘‘altered self’’ or ‘‘healthy self’’ can tailor the nature of the reactive
gliosis and multicellular responses to the type and severity of
cellular damage or death (Figures 4B and 4C). It is important to
note that the final level of cellular damage inflicted by insults of
all kinds is determined in part by prolonged periods of different
types of secondary events (Figure 1D), including a balancing
act among innate immune mechanisms that regulate the clear-
ance of ‘‘altered-self’’ debris and ‘‘non-self’’ pathogens, while
preserving ‘‘healthy self’’ (Figure 4C) (Griffiths et al., 2010). These
events will impact on final size, location of glial scar, and
signaling to perlesion perimeters (Figure 2).
Reactive Gliosis
Reactive gliosis is regulated by a large array of different extracel-
lular signals generated after CNS insults. This array includes
not only molecules released by damaged or dead cells as justdescribed, but alsomolecules entering via leaky BBB,molecules
released by infiltrating leukocytes, and molecules released
by local cells including reactive glia themselves (Figure 5A)
(Sofroniew, 2009). In response to these many different and often
combinatorial molecular signals, reactive glia alter their gene
expression, structure, and function in selective and specific
ways, depending on the type and severity of the insults and de-
pending on the specific combinations of molecular signals that
are impinging on them. It is important to emphasize that glia
do not exist in simple all-or-none ‘‘quiescent’’ or ‘‘activated’’
states and that there is no single program of ‘‘reactive gliosis’’
that is triggered in an all-or-none fashion and is similar in all
situations. Instead, reactive glia can exhibit a vast range of re-
sponses as determined by combinations of specific signaling
events. For example, exposure to PAMPs such as lipopolysac-
charide (LPS) can markedly skew the transcriptome of reactive
astrocytes toward chemokines, cytotoxicity, and inflammation
(Hamby et al., 2012; Zamanian et al., 2012). It is also noteworthyNeuron 81, January 22, 2014 ª2014 Elsevier Inc. 239
Figure 5. Multicellular and Multimolecular
Regulation of Reactive Gliosis and BBB
(A) Reactive gliosis can be induced, regulated, and
influenced by a wide variety of molecular signals
that can derive from many types of CNS intrinsic
and extrinsic sources.
(B) BBB permeability can be regulated by spe-
cific molecular signaling cascades involving in-
teractions among different cell types that converge
on endothelial tight junctions (Argaw et al., 2009,
2012; Seo et al., 2013).
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synergistic changes in molecular expression that could not be
predicted from individual effects (Hamby et al., 2012).
Information about the effects mediated by reactive glia in
response to specific signals is also steadily increasing and it is
clear that many aspects of reactive gliosis are part of coordi-
nated multicellular innate and adaptive immune responses to
CNS insults. It is interesting to consider that certain molecules
are emerging as potential coordinators of multicellular re-
sponses. One interesting set of converging data implicates IL-
1b as a key trigger that stimulates different types of glial cells
to modulate BBB permeability to serum proteins and leukocytes
during reactive gliosis in response to CNS insults (Figure 5B).
Numerous DAMPs and PAMPs generated by CNS insults will
stimulate IL-1b release from microglia, and this IL-1b will stimu-240 Neuron 81, January 22, 2014 ª2014 Elsevier Inc.late (1) local reactive astrocytes to release
VEGF and (2) local NG2-OPCs to release
MMP-9, which in turn influence tight junc-
tions and barrier properties of local endo-
thelial cells and allow entry of serum
proteins (including IgGs and signaling
proteins such as thrombin, albumin, pro-
teases, etc.) and leukocytes into local
CNS parenchyma (Figure 5B) (Argaw
et al., 2009, 2012; Seo et al., 2013).
Entering leukocytes have the potential to
generate more IL-1b and sustain local
BBB permeability, creating the potential
for a feedforward loop under adverse cir-
cumstances. Understanding the molecu-
lar mechanisms whereby such signaling
is downregulated and the BBB reseals
may help to reveal rational therapeutic in-
terventions for certain conditions. Repair
of the BBB after an uncomplicated acute
injury generally occurs within several
weeks (Figure 1D).
Astrocyte Scar Formation
Formation of compact astrocyte scars is a
specialized aspect of reactive astrogliosis
that occurs in response to severe tissue
damage and leukocyte infiltration and
involves phases of cell proliferation and
cell organization (Figure 1) (Sofroniew
and Vinters, 2010; Wanner et al., 2013).
Molecular signals that regulate astrocyteproliferation signals after CNS damage can derive from serum
proteins or local cells and include thrombin, endothelin, FGF2,
ATP, bone morphogenic proteins (BMPs), sonic hedge hog
(SHH), and others (Table 2) (Gadea et al., 2008; Neary et al.,
2003; Sahni et al., 2010; Shirakawa et al., 2010; Sirko et al.,
2013). The location of astrocyte scar borders around lesions
can be influenced by interactions among proliferating or newly
proliferated scar-forming astroglia, fibroblast-linage cells, and
inflammatory cells (Wanner et al., 2013) and can be modulated
by transgenic manipulation of astrocyte intrinsic signaling cas-
cades involving STAT3, SOCS3, or NFkB, which can increase
or decrease lesion sizes (Brambilla et al., 2005; Herrmann
et al., 2008; Okada et al., 2006; Wanner et al., 2013), providing
targets for potential intervention. Signals for organization of
newly proliferated astrocytes into compact scars include the
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astrocyte scar formation after trauma, infection, and autoim-
mune inflammation (Dro¨gemu¨ller et al., 2008; Haroon et al.,
2011; Herrmann et al., 2008; Wanner et al., 2013).
Neural Remodeling in Perilesion Perimeters
Reactive gliosis is not only important in responses to very local
CNS damage, but also is likely to play important roles in the neu-
ral remodeling that continues for prolonged times in perilesion
perimeters after acute focal insults such as stroke and trauma
(Figures 1 and 2), as well as in chronic diffuse CNS insults
(Figures 3) including neurodegenerative conditions such as Alz-
heimer’s disease. Such perilesion perimeter regions can extend
for considerable distances away from large focal lesions (Figures
1 and 2) or can cover large areas of diffuse tissue damage (Fig-
ures 3). In such cases, the associated reactive gliosis has the po-
tential to impact on substantial territories of functioning neural
tissue. There is mounting evidence that the diverse changes in
molecular signaling associated with this diffuse reactive gliosis
(Table 2) will impact on the ongoing neural remodeling and
changes in neural function. Astrocytes interact with neurons on
multiple spatial and temporal scales that can influence or modu-
late neural function in various direct and indirect ways, including
by modulation of the extracellular balance of ions, transmitters,
and water critical for neural function, as well as direct influences
on synaptic activity directly via release of ‘‘gliotransmitters’’
(Halassa and Haydon, 2010; Hamilton and Attwell, 2010; Henne-
berger et al., 2010; Volterra and Meldolesi, 2005). Microglia are
also implicated in participating in the regulation of synaptic turn-
over (Stephan et al., 2012). Perineuronal net molecules such as
chondroitin sulfate proteoglycans generated by astrocytes and
NG2-OPC influence synaptic plasticity (Table 2) (Wang and Faw-
cett, 2012). The effects of reactive gliosis on such functions is
only beginning to be understood, but reactive astrogliosis has
been reported to impact on neural functions in various ways,
including (1) by downregulation of astrocyte glutamine synthase
that is associated with reduced inhibitory synaptic currents in
local neurons (Ortinski et al., 2010), (2) increased expression of
xCT (Slc7a11), a cysteine-glutamate transporter associated
with increased glutamate signaling, seizures, and excitotoxicity
(Buckingham et al., 2011; Jackman et al., 2010), and (3) changes
in the expression of multiple GPCRs and G proteins and calcium
signaling evoked by their ligands that have the potential to alter
astrocyte-neuron interactions (Hamby et al., 2012). There is
also a growing body of evidence that in response to inflammatory
mediators and cytokines, reactive astrocytes can modulate their
expression of multiple molecules such as transmitter and ion
transporters, neuromodulators such as nitric oxide and prosta-
glandins, growth factors, and synapse regulatory proteins, which
can impact on synaptic and neuronal functions including com-
plex behaviors such as sickness behavior, pain, appetite, sleep,
and mood, as reviewed in more detail elsewhere (Sofroniew,
2013). Taken together, such findings provide evidence that
different molecular mediators and signalingmechanisms associ-
ated with reactive gliosis can modulate functions of reactive as-
trocytes andmicroglia in different ways that have the potential to
impact on synaptic and other neuronal functions in perilesion
perimeters. Such signaling mechanisms are likely to have effects
on the efficacy of training and functional rehabilitation after acutedamage such as trauma or stroke, as well as effectors tomitigate
functional deterioration during degenerative conditions. Under-
standing and manipulating the signaling mechanisms and
effects of reactive gliosis in perilesion perimeter tissue has the
potential to reveal novel therapeutic strategies (Gleichman and
Carmichael, 2013).
Blood-Brain Barrier
The blood-brain barrier (BBB) is generated and regulated by a
complex multicellular neurovascular unit that involves critical
interactions among endothelia, pericytes, astrocytes, and other
cells (Abbott et al., 2006; Zlokovic, 2008). Compromise of the
BBB can occur in various manners and to various degrees,
ranging from specific molecular signaling events that open
BBB permeability during certain types of reactive gliosis as dis-
cussed above (Figure 5B), to severe breakdown of the BBB
caused by traumatic or ischemic endothelial destruction result-
ing in the need for neovascularization (Figure 1). In addition to
overt trauma and ischemia, considerable evidence implicates a
central role for BBB dysfunction in aging and various neurode-
generative disorders. For example, both transgenically induced
and aging-related pericyte deficiencies result in BBB breakdown
that precedes neuronal degeneration (Bell et al., 2010). Pericyte
deficiency is also apparent in postmortem amyotrophic lateral
sclerosis tissue (Winkler et al., 2013) and BBB dysfunction pre-
cedes neurodegeneration in a murine model (Zhong et al.,
2008). Polymorphisms in APOE isoforms are implicated in
increased vulnerability to BBB breakdown in neurodegenerative
disorders and traumatic injury (Bell et al., 2012).
Regardless of triggering events, BBB leaks lead immediately
to CNS parenchymal entry of serum proteins such as thrombin,
albumin, immunoglobulins, and proteases (Figure 5B) that can
have a wide range of direct and indirect effects. Thrombin can
signal directly via protease-activated receptors on various CNS
cells including microglia and astrocytes (Shigetomi et al., 2008;
Suo et al., 2002). Immunoglobulins contribute to clearing of path-
ogens but may contribute to autoimmune dysfunctions. Platelets
can enter and form aggregates for clotting and release PDGFs,
important for neovascular remodeling as well as for signaling
to pericytes and NG2 cells. Metaloproteases act onmultiple pro-
teins and contribute to extracellular matrix and tissue remodeling
(Table 2). Serum kallikrein proteases activate inflammation. Tis-
sue kallikreins, which can interact with serum proteases as part
of larger proteolytic cascades, are implicated in oligodendrocyte
pathology, demyelination, axonopathy, and neuronal degenera-
tion (Burda et al., 2013; Radulovic et al., 2013). Serpins inhibit
and balance protease effects (Table 2).
In response to signals associated with BBB leak, local glial
cells produce cytokines and chemokines that attract leukocytes,
which on arrival produce additional cytokines and chemokines.
The result is a rich extracellular mixture of molecular signals
that can instruct or influence multiple cell types in lesion cores
and can also diffuse away into surrounding CNS parenchyma
and influence neural cells that may not have been involved in
the initial insult (Figure 2). These molecular gradients may influ-
ence or take part in shaping cellular events in the perilesion pe-
rimeters such as the long-lasting gradient of reactive gliosis and
the long-lasting neural remodeling that occurs in perimeter tis-
sue. The mix of molecular signals generated in lesion coresNeuron 81, January 22, 2014 ª2014 Elsevier Inc. 241
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different phases and the BBB leak is repaired and different cell
types occupy this area and produce different effector molecules
(Figure 1D; Table 2). Depending on the severity of the insult,
lesion cores exhibit a BBB leak for at least several days up to
2 weeks throughout the initial period (Phase I) of damage
response (Figure 1D). BBB repair requires the presence of func-
tional astrocytes (Bush et al., 1999). Release of the protein
HMGB1 by reactive astrocytes promotes endothelial cell neo-
vascular remodeling, whereas blockade of HMGB1 release by
reactive astrocytes prevents neovascular remodeling and
worsens neurological deficits (Hayakawa et al., 2012). In com-
plex, chronic, or diffuse insults, BBB leaks may persist and
have long-lasting effects on extended areas of neural tissue in
perilesion perimeters (Figure 3), and late BBB disruption may
lead to secondary tissue injury (Zlokovic, 2008). Even when
BBB leaks are repaired, lesion cores continue to contain collec-
tions of nonneural cells within the BBB that have the potential to
continue producing high levels of many different signaling mole-
cules for prolonged periods. Thus, lesion core tissue has the po-
tential to generate diffusion gradients of many potent molecules
that spread into neighboring tissue parenchyma and form gradi-
ents of molecular signals that influence host cells (Figure 2). It is
also noteworthy that while the BBB is open, there is also the
potential for entry of various pathogen-associated molecular
patterns (PAMPs) (Table 2) that are generated by microbial
infections in the periphery and that can substantively alter the
response of local cells to CNS damage, even when there is no
local infection, as discussed below.
Infiltrating Leukocytes
Leukocytes that infiltrate from the circulation provide a major
source of molecular signaling during responses to CNS
damage. These molecular signals include a diverse mix of
cytokines, chemokines, and growth factors (Table 2) that can
instruct and modify the functions of local reactive glia
(Figure 5A) and other intrinsic CNS cells as well as other local
leukocytes. It is likely that the molecular signals produced by
leukocytes, and their functional effects, will vary during different
phases of response to acute or chronic insults (Figure 1) and
range from those mediating classical inflammatory responses
with cytotoxic and phagocytic activities, to those influencing
tissue repair and remodeling. Although temporal changes
during wound responses are not yet well studied, different
functional roles for different leukocyte subtypes are gradually
coming into focus. For example, in response to stimulation by
different cytokines, monocytes generate macrophages with
distinct functional phenotypes that produce different effector
molecules (Mosser and Edwards, 2008). In response to INFg,
classically activated macrophages generate cytotoxic antimi-
crobial molecules and phagocytose dead cells and debris
(Figure 4C), whereas in response to stimulation with IL-4 or
IL-10, macrophages take part in wound healing and anti-inflam-
matory activities (Mosser and Edwards, 2008). Similarly,
T cells stimulated by different cytokines become polarized
toward different activities, such as TH1, TReg, and TH17 cells,
which can exert very different effects ranging from cell killing
to participation in tissue repair (MacIver et al., 2013; Mills,
2011; Walsh and Kipnis, 2011).242 Neuron 81, January 22, 2014 ª2014 Elsevier Inc.Impact of Peripheral Infections on Responses to CNS
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Many of the cell types responding to CNS damage are exqui-
sitely sensitive to molecular cues associated with microbial
infection. This is not surprising because limiting infection spread
is likely to have shaped the evolution of injury responses in all tis-
sues including CNS. Various features of the response to infection
such as production of cytotoxins and certain types of inflamma-
tion can damage host cells as well as microbes. Triggering such
responses in the absence of overt infection has the potential to
cause or exacerbate tissue damage. Thus, certain responses
that may be beneficial in microbial infection may be detrimental
if triggered during sterile (uninfected) tissue damage after
trauma, stroke, degenerative disease, or autoimmune attack.
In this regard, it is important to recognize that reactive glia,
both microglia and astrocytes, that are responding to a sterile
primary CNS insult can be influenced by peripheral infections
that generate high levels of circulating cytokines and other
inflammatory mediators such as LPS and other PAMPs. This
signaling can occur through blood-borne cytokines or LPS
released at the site of peripheral infection and entering through
the leaky BBB in the injury core during phase I of the damage
response after focal insults or through BBB leaks triggered by
neurodegenerative or autoimmune processes (Figures 1A and
5A). LPS and cytokines have powerful effects both on reactive
microglia (Perry, 2010; Perry et al., 2007) and on reactive astro-
cytes (Hamby et al., 2012; Zamanian et al., 2012) that can drive
transcriptome profiles and wound response toward proinflam-
matory and potentially cytotoxic phenotypes over prolonged
times in ways that would not normally be implemented in sterile
CNS insults and that can exacerbate tissue damage. Congruent
with such experimental observations is clinical epidemiological
evidence indicating that peripheral infections have a negative
impact on neurological outcome after spinal cord injury (Failli
et al., 2012).
Common Features, Differences, and Building Models
Given the large number of potential CNS insults and the consid-
erable amount of variation among the multicellular responses
they elicit, looking for common features and clear differences
may provide valuable insights regarding shared fundamental
mechanisms. Understanding basic factors that drive responses
to one type of insult may inform ideas regarding responses to
another. In this regard, it is interesting to consider that evolu-
tionary pressures shaping responses to CNS damage are likely
to have favored rapid responses to small CNS injuries that
were not functionally incapacitating and that kept such injuries
small and uninfected or that kept small infections from
spreading. One efficient means of doing so would be to isolate
small focal injuries or small infections with cellular barriers that
effectively wall off these lesions, allowing a robust inflammatory
(and antimicrobial) responses in lesion cores, while preserving as
much adjacent neural tissue as possible (Sofroniew, 2005). In
this Review, based on available information, we present a basic
model of multicellular responses to different types of focal CNS
tissue damage that is compatible with this notion (Figures 1, 2,
and 3). Certain common features in this model of cellular re-
sponses to CNS damage could be interpreted as serving the
Figure 6. Lesions as Targets for Therapeutic Strategies
Nonneural lesion cores (LC) represent targets for biomaterial depots (A) or grafts of exogenous neural stem/progenitor cells (B), or mesenchymal stem cells (C) as
potential therapeutic strategies. Molecules delivered by biomaterial depots (A) or certain cell grafts (C) have potential to support and attract axon growth (arrow a),
modulate cells in perilesion perimeter (PLP) (arrow b), modulate cells in LC (arrow c), or modulate astrocyte scar (AS) (arrow d). New neurons generated by stem/
progenitor cell grafts can receive and send neural connects in PLP and beyond and may be able to form new, functional relay circuits (B).
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focal infection. Viewing certain cellular responses to other CNS
insults in this light may provide insights regarding basic mecha-
nisms and how to understand and eventually manipulate re-
sponses safely to improve outcomes. We of course recognize
that not all responses will be determined or influenced in this
manner. Nevertheless, the powerful and fundamental role of
response to infection is likely to be ancestral to all responses
to CNS damage and therefore has the potential to influence all
types of responses that evolved subsequently. This point is un-
derscored by the growing recognition of the role of inflammatory
mechanisms in different neurodegenerative diseases, and the
potential for molecules released by peripheral infections to influ-
ence far-distant reactive gliosis as discussed above. It is impor-
tant to realize that the multicellular responses to diffuse CNS
insults are likely to have been shaped by adapting already exist-
ing responses to focal traumatic damage or focal infection.
This notion is likely to apply not only to degenerative diseases,
but also to autoimmune-mediated damage, where the CNS
response to such damage bears striking similarities to responses
to other forms of CNS tissue damage. This discussion ismeant to
highlight the usefulness of constructing models of how multiple
cells interact and how multiple molecules drive these interac-
tions during the responses to different types of CNS damage.
The models we have presented here are compatible with basic
evidence currently available but no doubt will require modifica-
tion as information accrues. We hope that they are flexible
enough to accommodate modifications and can serve as useful
frameworks.
Manipulating CNSWound Responses to Promote Repair
As the cell biology and molecular signaling that underlie re-
sponses to CNS damage become defined, there is increasingpotential for identifying ways to manipulate these responses to
improve outcome. Manipulations under intense investigation
include not only traditional approaches such as development
of drug candidates for parenteral pharmacological delivery, but
also lifestylemodifications such as reduced energy consumption
and implementation of exercise strategies intended to reduce
inflammatory responses, cellular degeneration, and functional
decline after stroke and traumatic injury (Arumugam et al.,
2010; Mattson, 2012; Piao et al., 2013). In addition, novel inter-
ventional strategies in the form of biomaterial implants as
molecular depots for local molecular delivery, as well as tissue
regenerative approaches based on transplantation of progenitor
or stem cells, are showing considerable promise for future appli-
cation in neural repair and regeneration. The nonneural lesion
cores of focal lesions may represent particularly useful targets
for such approaches (Figure 6). For example, biomaterial im-
plants, particularly in the form of injectable hydrogels, have po-
tential to serve both as scaffolds and depots that can influence
tissue remodeling and cellular functions (Pakulska et al., 2012).
Large lesion cores of nonneural tissue after stroke or severe focal
trauma may represent useful sites for placement of biomaterial
depots that release gradients of molecules to influence locally
surrounding neural tissue without inflicting additional damage
(Figure 6A). For example, injectable hydrogel depots can provide
sustained delivery of different kinds of bioactive molecules,
including growth factors or small hydrophobicmolecules to influ-
ence gene expression and function of local cells over prolonged
subacute times, after which they are degraded without substan-
tive tissue damage (Pakulska et al., 2012; Song et al., 2012; Yang
et al., 2009; Zhang et al., 2014). Such molecular delivery has the
potential to influence not only the ongoing repair in the subacute
period after injury such as scar formation, but also can influence
cells in the large perimeter zone around CNS lesions thatNeuron 81, January 22, 2014 ª2014 Elsevier Inc. 243
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after tissue damage (Figure 6A). Delivery of molecules via depots
placed into lesion cores have the potential to influence the neural
plasticity and tissue remodeling in this perimeter region (Clark-
son et al., 2010).
Various cellular regenerative approaches may have potential
for CNS repair (Bliss et al., 2007; Martino and Pluchino, 2006;
Snyder and Teng, 2012). Delivery of neural-lineage progenitor
or stem cells into lesion cores (Figure 6B) can lead to the gener-
ation of local neurons that form afferent and efferent connections
with host and have the potential to form functionally integrated
circuits (Abematsu et al., 2010; Lu et al., 2012). Stromal or
mesenchymal stem cells derived from bone marrow or umbilical
cord, delivered by peripheral (intravascular) or CNS injection,
can home to injury sites (Figure 6C), where they can release
growth factors, cytokines, and other factors that may influence
the response to damage and repair process (Bliss et al., 2007;
Kokaia et al., 2012; Lemmens and Steinberg, 2013). Such
grafting studies are being intensely pursued but are still in the
early stages of development. Beneficial effects are reported on
cellular events such as immunomodulation, survival of CNS
intrinsic cells including neurons, and growth of axons; however,
limited information is as yet available on overall functional
efficacy.
Concluding Remarks
The study of cellular responses to CNS injury has progressed
enormously in the last two decades, as have ideas about their
functions and mechanisms. It is now clear that reactive gliosis
and multicellular responses to CNS damage are a complex
mixture of events that balance clearance of dead cells, patho-
gens, and debris with maximal preservation of adjacent local tis-
sue. These events are regulated by a vast number of molecular
signals that control specific cellular functions as dictated by spe-
cific situations. Reactive gliosis is not all-or-none or stereotypic;
instead, it is highly variable and context specific. Loss-of-
function studies show that reactive gliosis and multicellular re-
sponses to CNS damage exert essential beneficial functions
without which tissue damage (and function) would increase
and tissue repair would not occur. Nevertheless, over activity
of certain functions may in some cases exacerbate tissue dam-
age. Interventions to block such activities will need to target spe-
cificmolecular events rather than attempt to block the process of
gliosis per se.
Understanding the ways in which dysfunction of reactive glio-
sis and multicellular responses to CNS damage can occur, for
example, through genetic mutations or polymorphisms, has
the potential to identify new mechanisms that may underlie
specific CNS disorders or that may underlie population vari-
ability in responses to similar insults such as stroke or trauma.
There is a compelling need to deepen our understanding of
specific cellular interactions during responses to CNS insults,
and how these change over time and are governed by complex
molecular signaling mechanisms. Such information is funda-
mental to understanding most CNS disorders and for devel-
oping rationally targeted therapeutic strategies that can safely
manipulate or modify cellular responses to CNS insults in
ways that improve outcome.244 Neuron 81, January 22, 2014 ª2014 Elsevier Inc.ACKNOWLEDGMENTS
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